Gyro New York has been selected by Medidata, provider of solutions and analytics for clinical research, as its creative partner in the new 'Architecture of Hope' campaign. The messaging showcases how technology in the life sciences can drive better outcomes, breakthroughs and hope for patients.
The company is collaborating specifically with the agency’s global healthcare practice, Gyro Human to illustrate ongoing work in the life sciences industry and the pivotal role that Medidata plays in the pursuit of therapies for patients.
“We're proud to accelerate hope for our life sciences customers and partners, providing cloud technology and data insights to streamline medical research and deliver better therapies to patients sooner,” said Simon Mouyal, Medidata’s chief marketing officer. “Gyro understands the complexity of the healthcare space, and we’re confident that together we will elevate our brand and communicate the value we bring to the entire clinical trials ecosystem.”
Medidata and Gyro worked together to develop and roll out the 'Architecture of Hope' messaging to highlight the company’s expertise in study planning, site support, patient engagement, study conduct and study outcome optimization. With 17 years of industry experience in the life sciences vertical, the Medidata platform has been used in more than 12,000 clinical studies, 420,000 investigational sites and more than 3.1m trial volunteers.
“Our healthcare expertise was central to helping us understand not only the solutions themselves, but also the healthcare audiences and the higher purpose that Medidata serves,” added Wendy Lurrie, managing director of gyro New York and Gyro Human.